Group One Trading
NAVB

Group One Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Group One Trading’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-300
Closed -$27 – 8523
2023
Q3 		$27 Hold
300
– – ﹤0.01% 7517
2023
Q2 		$28 Buy
+300
New +$48 ﹤0.01% 7553
2022
Q4 		– Sell
-190,752
Closed -$48K – 8551
2022
Q3 		$48K Sell
190,752
-36,700
-16% -$17.1K ﹤0.01% 5448
2022
Q2 		$164K Buy
227,452
+7,352
+3% +$6.25K ﹤0.01% 4491
2022
Q1 		$174K Buy
220,100
+62,700
+40% +$57.5K ﹤0.01% 4949
2021
Q4 		$157K Buy
157,400
+147,713
+1,525% +$208K ﹤0.01% 5334
2021
Q3 		$17K Buy
9,687
+8,998
+1,306% +$15.1K ﹤0.01% 7277
2021
Q2 		$1K Sell
689
-27,815
-98% -$49.2K ﹤0.01% 8066
2021
Q1 		$58K Buy
28,504
+9,846
+53% +$23K ﹤0.01% 6121
2020
Q4 		$40K Sell
18,658
-4,196
-18% -$9.89K ﹤0.01% 5157
2020
Q3 		$62K Buy
22,854
+1,104
+5% +$3.96K ﹤0.01% 4518
2020
Q2 		$86K Buy
+21,750
New +$41.6K ﹤0.01% 4031
2020
Q1 		– Sell
-29,848
Closed -$32.9K – 6141
2019
Q4 		$38K Buy
29,848
+6,545
+28% +$5.65K ﹤0.01% 4134
2019
Q3 		$16K Buy
23,303
+19,403
+498% +$11.9K ﹤0.01% 4449
2019
Q2 		$2K Buy
+3,900
New +$7.56K ﹤0.01% 4796
2018
Q3 		– Sell
-41
Closed – – 5898
2018
Q2 		$0 Hold
41
– – ﹤0.01% 5725
2018
Q1 		$0 Sell
41
-737
-95% -$5.51K ﹤0.01% 5604
2017
Q4 		$6K Hold
778
– – ﹤0.01% 4544
2017
Q3 		$6K Sell
778
-440
-36% -$3.73K ﹤0.01% 4455
2017
Q2 		$12K Buy
1,218
+813
+201% +$8.04K ﹤0.01% 4156
2017
Q1 		$5K Buy
+405
New +$4.6K ﹤0.01% 4308
2016
Q2 		– Sell
-1,068
Closed -$21K – 5135
2016
Q1 		$20K Buy
+1,068
New +$20.6K ﹤0.01% 3756
2015
Q4 		– Sell
-6,586
Closed -$229K – 5345
2015
Q3 		$300K Buy
6,586
+5,564
+544% +$210K ﹤0.01% 2199
2015
Q2 		$33K Sell
1,022
-1,385
-58% -$40.2K ﹤0.01% 3791
2015
Q1 		$77K Sell
2,407
-4,082
-63% -$138K ﹤0.01% 3078
2014
Q4 		$245K Buy
6,489
+1,385
+27% +$38.1K ﹤0.01% 2137
2014
Q3 		$135K Sell
5,104
-2,268
-31% -$60K ﹤0.01% 2733
2014
Q2 		$218K Sell
7,372
-1,203
-14% -$38.9K ﹤0.01% 2332
2014
Q1 		$317K Buy
8,575
+3,907
+84% +$148K 0.01% 2048
2013
Q4 		$193K Buy
+4,668
New +$183K ﹤0.01% 2471
2013
Q3 		– Sell
-1,246
Closed -$72.6K – 5802
2013
Q2 		$67K Buy
+1,246
New +$62.2K ﹤0.01% 3174

Other funds holding NAVB

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Group One Trading's NAVB Position: Q4 2023 in Review

Group One Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2023, closing a stake of 300 shares — an estimated $27 sold.

Group One Trading first reported a position in NAVB in Q2 2013 and held it in 31 quarters. The position peaked at $317K in Q1 2014. 4 funds tracked by Wall St. Rank hold NAVB as of Q4 2023.

  • Group One Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 300 Navidea Biopharmaceuticals Inc. shares in Q4 2023, an estimated $27.
  • Group One Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 31 quarters.
  • Group One Trading's Navidea Biopharmaceuticals Inc. position peaked at $317K in Q1 2014.
  • 4 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.